Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the pricing of an underwritten ...

Affirm Holdings, Inc. ( AFRM) Discusses BNPL Growth, Competitive Differentiation, and Consumer Value in Payments December 16, 2025 12:00 PM EST ...

The shares described above are being offered by Kodiak Sciences pursuant to a shelf registration statement on Form S-3, including a base prospectus, that was previously filed by Kodiak Sciences with ...

Michael van der Straaten, CEO of Antares Global, a London-based specialty insurer, offers his outlook on the specialty ...

ASIC commissioner Kate O’Rourke said conflicts of interest remain a material concern for the financial system. “Conflicts of ...

Upbound Group receives a Hold rating due to credit stress in Acima, high leverage, and mixed segment performance. Learn more ...

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Brookfield today published its 2026 Investment Outlook, which highlights that the defining forces shaping the global economy are accelerating, creating one ...

AI mega-rounds, fewer seed deals, and private equity’s rise are redefining venture capital in 2025. What founders need to ...

Snowy Hydro will be paid to operate its Tumut pumped hydro facilities as "syncons" to provide system strength to the grid. But we are not told how much.

Corebridge stands out for its low term life insurance premiums, but it also has higher-than-average complaints ...

ASIC commissioner Kate O’Rourke said conflicts of interest remain a material concern for the financial system. “Conflicts of ...

The gross proceeds to Rekor from the offering are approximately $15 million, before deducting underwriting discounts and commissions and other offering expenses payable by Rekor. Rekor intends to use ...